Farah Nabil and M. Saleem, “First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort”, MECOJ, vol. 2, no. 2, pp. 11–17, Apr. 2026, doi: 10.61706/MECOJ160191.